跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 204 条关于
“Etuvetidigene autotemcel”
全部
204
临床试验
86
药物
36
机构
0
资讯
82
去年
Telethon Foundation Seeks EMA Approval for Etuvetidigene Autotemcel in Wiskott-Aldrich Syndrome
9个月前
FDA Approves First Gene Therapy for Wiskott-Aldrich Syndrome
10个月前
EMA Recommends First Gene Therapy for Wiskott-Aldrich Syndrome
10个月前
European Regulators Recommend Approval for Waskyra Gene Therapy for Rare Wiskott-Aldrich Syndrome
9个月前
FDA Approves First Gene Therapy for Wiskott-Aldrich Syndrome, Marking Historic Milestone for Non-Profit Drug Development
去年
FDA Investigates Blood Cancer Risk Linked to Bluebird Bio's Skysona Gene Therapy
去年
CASGEVY Shows Durable Clinical Benefits in Sickle Cell Disease and Beta Thalassemia
12个月前
Bluebird Bio Rebrands as Genetix Biotherapeutics Following Private Buyout, Refocuses on Gene Therapy Access
6年前
Gene Therapy Shows Promise in Treating Severe β-Thalassemia
去年
Pfizer Withdraws Sickle Cell Drug Oxbryta After EMA Reports Deaths in Trials
第 1 页,共 9 页
上一页
下一页